Skip to main content

Detact Diagnostics

Delfzijl, The Netherlands

Detact holds the patent for a new, innovative, real-time, bacterial detection system that enables hospital staff.

$5.9M raised
Nov 2025
Grant

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Detact Diagnostics

How much funding has Detact Diagnostics raised?
Detact Diagnostics has raised $5.9M in total funding. The most recent round was Grant. The last funding was announced in November 2025.
Who are Detact Diagnostics's investors?
Detact Diagnostics's investors include Bill & Melinda Gates Foundation, NV NOM, Pacific 6 Enterprises, JM Molina Investments.
Where is Detact Diagnostics headquartered?
Detact Diagnostics is headquartered in Delfzijl, The Netherlands.
What does Detact Diagnostics do?
Detact holds the patent for a new, innovative, real-time, bacterial detection system that enables hospital staff.
What stage is Detact Diagnostics at?
Detact Diagnostics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Detact Diagnostics — Funding & Investors." VCBacked, November 7, 2025, https://www.vcbacked.co/company/detact-diagnostics. Accessed July 2, 2026.
APA
VCBacked. (2025). Detact Diagnostics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/detact-diagnostics
Wikipedia (cite web)
{{cite web |title=Detact Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/detact-diagnostics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .